Table 1. The definition of pathways.
Positive Effects | ||||
TP53 | PIK3C1/AKT | PI3KC2 | RAS | RB |
CDKN2A | AKT1 | PIK3C2A | ARAF | CDKN1A |
TTP53 | AKT2 | PIK3C2B | BRAF | CDKN1B |
AKT3 | PIK3C2G | EGFR | CDKN2A | |
GAB1 | ERBB2 | CDKN2B | ||
IRS1 | ERBB3 | CDKN2C | ||
PIK3CA | FGFR1 | RB1 | ||
PIK3CB | FGFR2 | |||
PIK3CD | GRB2 | |||
PIK3CG | HRAS | |||
PIK3CR1 | IGFR | |||
PIK3CR2 | KRAS | |||
PDPK1 | MET | |||
SRC | NRAS | |||
PDGFRA | ||||
PDGFRB | ||||
RAF1 |
We split all genes into those with negative effects on the pathway and those with positive effects. Each column is headed by the name of the signaling pathway in which the genes reside, followed by the list of genes. A gene with positive effect increases the generation of the pathway's product when amplified, while a negative effect gene decreases its production when amplified. Deletion of a gene has the reverse effect on the pathway.